Chlorhexidine Gluconate Rinse
NDC Package 17856-2002-4
Package Information
Chlorhexidine Gluconate rinses is a medication used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. This formulation utilizes a rinse delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-2002 and is authorized under FDA application ANDA077789.
Identification & Billing
- RxCUI: 834127 - chlorhexidine gluconate 0.12 % Oral Rinse
- RxCUI: 834127 - chlorhexidine gluconate 1.2 MG/ML Mouthwash
- RxCUI: 834127 - chlorhexidine gluconate 0.12 % Mouthwash
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-2002 - Chlorhexidine Gluconate
- 17856-2002-4 - 40 SYRINGE in 1 BOX, UNIT-DOSE / 15 mL in 1 SYRINGE
- 17856-2002 - Chlorhexidine Gluconate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-2002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-2002-4 identifies a specific commercial package of 40 syringe in 1 box, unit-dose / 15 ml in 1 syringe of Chlorhexidine Gluconate, a human prescription drug labeled by Atlantic Biologicals Corp.. This rinse is formulated for oral use and contains chlorhexidine gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on June 01, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. Chlorhexidine belongs to a class of drugs known as antimicrobials. It works by decreasing the amount of bacteria in the mouth, helping to reduce swelling and redness of the gums and bleeding when you brush.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856200204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.